First Citizens Bank & Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81M Buy
23,081
+202
+0.9% +$16.3K 0.03% 237
2026
Q1
$1.98M Sell
22,879
-1,116
-5% -$107K 0.04% 210
2025
Q4
$2.3M Sell
23,995
-1,438
-6% -$140K 0.05% 181
2025
Q3
$2.42M Sell
25,433
-1,571
-6% -$144K 0.05% 171
2025
Q2
$2.35M Sell
27,004
-8,668
-24% -$735K 0.04% 169
2025
Q1
$3.21M Sell
35,672
-2,578
-7% -$231K 0.08% 148
2024
Q4
$3.06M Sell
38,250
-2,767
-7% -$240K 0.06% 144
2024
Q3
$3.69M Buy
41,017
+1,098
+3% +$92.4K 0.08% 134
2024
Q2
$3.14M Buy
39,919
+954
+2% +$78.2K 0.06% 148
2024
Q1
$3.4M Buy
38,965
+14,451
+59% +$1.23M 0.07% 140
2023
Q4
$2.02M Buy
+24,514
New +$1.87M 0.04% 170
2023
Q2
Sell
-3,143
Closed -$253K 359
2023
Q1
$253K Sell
3,143
-948
-23% -$77.3K 0.01% 293
2022
Q4
$318K Sell
4,091
-45,194
-92% -$3.66M 0.01% 262
2022
Q3
$3.98M Buy
49,285
+452
+0.9% +$40.6K 0.13% 77
2022
Q2
$4.38M Sell
48,833
-1,886
-4% -$191K 0.16% 70
2022
Q1
$5.63M Buy
50,719
+1,838
+4% +$194K 0.22% 70
2021
Q4
$5.06M Sell
48,881
-486
-1% -$56.3K 0.2% 69
2021
Q3
$6.19M Sell
49,367
-612
-1% -$79.2K 0.3% 49
2021
Q2
$6.2M Sell
49,979
-2,727
-5% -$342K 0.29% 46
2021
Q1
$6.23M Buy
52,706
+215
+0.4% +$25.2K 0.29% 48
2020
Q4
$6.15M Sell
52,491
-2,448
-4% -$269K 0.31% 45
2020
Q3
$5.71M Sell
54,939
-2,306
-4% -$232K 0.4% 47
2020
Q2
$5.25M Buy
57,245
+25,477
+80% +$2.44M 0.44% 52
2020
Q1
$2.87M Sell
31,768
-1,039
-3% -$111K 0.35% 70
2019
Q4
$3.72M Buy
32,807
+28,419
+648% +$3.12M 0.36% 69
2019
Q3
$477K Buy
4,388
+1,443
+49% +$151K 0.06% 230
2019
Q2
$286K Sell
2,945
-38
-1% -$3.47K 0.03% 362
2019
Q1
$272K Sell
2,983
-580
-16% -$51.9K 0.03% 367
2018
Q4
$324K Sell
3,563
-166
-4% -$15.5K 0.04% 272
2018
Q3
$366K Sell
3,729
-1,144
-23% -$106K 0.04% 273
2018
Q2
$417K Sell
4,873
-5,346
-52% -$447K 0.05% 246
2018
Q1
$820K Buy
10,219
+32
+0.3% +$2.64K 0.11% 190
2017
Q4
$823K Sell
10,187
-750
-7% -$60.1K 0.11% 180
2017
Q3
$851K Buy
10,937
+362
+3% +$30.1K 0.11% 174
2017
Q2
$939K Sell
10,575
-1,227
-10% -$103K 0.12% 170
2017
Q1
$951K Buy
11,802
+67
+0.6% +$5.23K 0.12% 174
2016
Q4
$836K Sell
11,735
-1,602
-12% -$126K 0.09% 173
2016
Q3
$1.15M Sell
13,337
-1,604
-11% -$140K 0.1% 153
2016
Q2
$1.3M Sell
14,941
-1,228
-8% -$99.3K 0.12% 148
2016
Q1
$1.21M Buy
16,169
+796
+5% +$60K 0.1% 139
2015
Q4
$1.18M Sell
15,373
-6,108
-28% -$460K 0.09% 168
2015
Q3
$1.44M Sell
21,481
-2,535
-11% -$187K 0.11% 146
2015
Q2
$1.78M Buy
24,016
+3,493
+17% +$267K 0.12% 143
2015
Q1
$1.6M Sell
20,523
-178,699
-90% -$13.5M 0.11% 147
2014
Q4
$14.4M Buy
199,222
+141
+0.1% +$9.79K 1.1% 28
2014
Q3
$12.3M Sell
199,081
-3,573
-2% -$227K 1.01% 34
2014
Q2
$12.9M Buy
202,654
+5,230
+3% +$318K 1.1% 27
2014
Q1
$12.1M Buy
197,424
+283
+0.1% +$16.5K 1.1% 25
2013
Q4
$11.3M Sell
197,141
-85,313
-30% -$4.84M 1.03% 33
2013
Q3
$15M Buy
282,454
+16,103
+6% +$866K 0.57% 31
2013
Q2
$13.7M Buy
+266,351
New +$13.2M 0.56% 34

Other funds holding MDT

First Citizens Bank & Trust's MDT Position: Q2 2026 in Review

First Citizens Bank & Trust increased its Medtronic (MDT) stake by 0.88% in Q2 2026, buying an estimated $16.3K and bringing the position to 23,081 shares worth $1.81M. The position accounts for 0.03% of the portfolio, ranked #237.

First Citizens Bank & Trust first reported a position in MDT in Q2 2013 and has held it in 51 quarters since. The position peaked at $15M in Q3 2013. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • First Citizens Bank & Trust held 23,081 shares of Medtronic worth $1.81M as of Q2 2026.
  • First Citizens Bank & Trust bought 202 Medtronic shares in Q2 2026, an estimated $16.3K.
  • Medtronic made up 0.03% of First Citizens Bank & Trust's portfolio in Q2 2026, its #237 holding.
  • First Citizens Bank & Trust first reported a position in Medtronic in Q2 2013 and has held it in 51 quarters since.
  • First Citizens Bank & Trust's Medtronic position peaked at $15M in Q3 2013.
  • 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.